ICLR

ICON Public Limited Company

Price

$162.13

return (12m)

-8.83%

p/e

307.58

p/bv

1.39

DIVIDEND YIELD

0.00%

ICLR price

ICON

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ICLR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.35%

3 months

6.11%

1 year

-8.83%

2 years

-48.07%

5 years

-38.01%

10 years

115.80%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ICLR

Valuation

P/E

307.58

Sector -4.23

Industry -4.23

P/BV

1.39

Sector 2.11

Industry 2.11

P/Revenue (PSR)

1.57

Sector 2.05

Industry 2.05

EV/EBITDA

61.30

Sector -546.75

Industry -546.75

EV/EBIT

100.76

Sector -37.85

Industry -37.85

P/EBITDA

15.10

Sector -51.33

Industry -51.33

P/EBIT

44.09

Sector -39.56

Industry -39.56

P/Total Assets

0.79

Sector 1.25

Industry 1.25

P/Net Current Assets

-3.98

Sector -5.36

Industry -5.36

P/Working Capital

-70.01

Sector -1.24

Industry -1.24

EPS

0.55

Sector -1.92

Industry -1.92

BVPS

121.79

Sector 1.93

Industry 1.93

Efficiency

Gross Margin

23.91%

Sector 39.10%

Industry 39.10%

EBITDA Margin

11.23%

Sector -13,872.36%

Industry -13,872.36%

EBIT Margin

6.83%

Sector -4,235,733.26%

Industry -4,235,733.26%

Operating Margin

10.14%

Sector -36.62%

Industry -36.62%

Net Profit Margins

0.51%

Sector -37.41%

Industry -37.41%

Asset Turnover

0.13

Sector 0.03

Industry 0.03

Profitability

ROE

0.45%

Sector -60.49%

Industry -60.49%

ROA

0.26%

Sector -63.06%

Industry -63.06%

ROIC

3.80%

Sector -498.28%

Industry -498.28%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

0.95

Sector 2.90

Industry 2.90

Net Debt / EBITDA

5.10

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

8.39

Sector -10.24

Industry -10.24

Net Debt / Equity

0.13

Sector -38,821.65

Industry -38,821.65

Gross Debt / Equity

0.23

Sector -0.83

Industry -0.83

Equity/Assets

0.57

Sector 0.43

Industry 0.43

Liabilities/Assets

0.43

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

8.64%

Sector -

Industry -

5Y Earnings CAGR

-22.68%

Sector -

Industry -

Fundamentals ICLR

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF ICON ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$162.13

Fair Value

$38.82

Upside Return potential.

-76.05%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ICLR ICON Public Limited Company	$162.13	-8.83%	0.00%	307.58	1.39	0.45%	0.51%
JNJ Johnson & Johnson	$277.82	60.73%	1.98%	30.34	7.51	24.76%	21.48%
PFE Pfizer Inc.	$28.67	22.83%	6.28%	35.72	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$260.84	27.01%	2.66%	72.02	-76.66	-106.44%	9.81%
NVO Novo Nordisk A/S	$47.05	-12.95%	4.06%	11.16	5.92	53.11%	35.32%
MRK Merck & Co. Inc.	$151.13	83.70%	2.29%	114.53	8.64	7.55%	4.76%
AZN AstraZeneca PLC	$164.27	2.46%	1.99%	23.89	4.95	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.65	49.46%	3.79%	14.60	6.06	41.55%	18.85%
ZTS Zoetis Inc.	$75.60	-49.60%	2.68%	12.14	10.20	84.02%	27.77%
AMGN Amgen Inc.	$443.34	60.06%	2.28%	26.55	19.86	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$841.88	49.91%	0.58%	18.86	2.57	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$110.11	50.14%	0.00%	29.70	85.59	288.14%	24.86%
MCK McKesson Corporation	$920.40	33.76%	0.37%	20.12	-27.60	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$557.35	38.99%	0.00%	31.27	6.80	21.76%	35.00%
CAH Cardinal Health Inc.	$247.26	67.44%	0.87%	35.62	-20.64	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$42.74	15.20%	0.00%	12.57	2.28	18.14%	18.89%
ARGX argenx SE	$1,061.23	50.23%	0.00%	3.11	3.48	112.18%	44.41%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ICLR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ICON

ICON Public Limited Company

Average Investor10 user rating

4.0 (2 people)

United States

36 years

Founded: 1990

1998

Time since IPO - 28 years

14.650

Employees

ICON Public Limited Company (United States) is listed on the Nasdaq and has a market capitalization of $13.02 billion, with shareholders equity totaling $9.38 billion.

The company employs approximately 14.650 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ICON Public Limited Company reported $8.29 billion in revenue, generating net income of $42.34 million.

Key financial metrics include a P/E ratio of 307.58, a price-to-book (P/B) ratio of 1.39, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ICLR.

Market cap

$13.02 billion

Net worth

$9.38 billion

$9,378,160,000.00

Assets

$16.40 billion

$16,400,320,000.00

Total Shares Outstanding

77.00 million

77,000,000

Average Daily Trading Volume

$801.63 Thousand

$801,630.00

Sector

Health Care

Industry

Biotechnology

ICLR

ICLR revenue and profits

Financial Results ICLR

DRAG THE FRAME TO SEE MORE DATA

ICLR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$920.40 33,91% (12M)

P/E

20.12

0.37%

ROE

-137.16%

P/BV

-27.60

CAH - Cardinal Health

$247.26 66,32% (12M)

P/E

35.62

0.87%

ROE

-57.93%

P/BV

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12M)

P/E

30.34

1.98%

ROE

24.76%

P/BV

7.51

ABBV - AbbVie

$260.84 27,05% (12M)

P/E

72.02

2.66%

ROE

-106.44%

P/BV

-76.66

MRK - Merck & Co.

$151.13 86,53% (12M)

P/E

114.53

2.29%

ROE

7.55%

P/BV

8.64

AZN - AstraZeneca

$164.27 2,88% (12M)

P/E

23.89

1.99%

ROE

20.74%

P/BV

4.95

PFE - Pfizer

$28.67 23,78% (12M)

P/E

35.72

6.28%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$920.40 33,91% (12 M)

P/L

20.12

0.37%

ROE

-137.16%

P/VP

-27.60

CAH - Cardinal Health

$247.26 66,32% (12 M)

P/L

35.62

0.87%

ROE

-57.93%

P/VP

-20.64

JNJ - Johnson & Johnson

$277.82 60,78% (12 M)

P/L

30.34

1.98%

ROE

24.76%

P/VP

7.51

ABBV - AbbVie

$260.84 27,05% (12 M)

P/L

72.02

2.66%

ROE

-106.44%

P/VP

-76.66

MRK - Merck & Co.

$151.13 86,53% (12 M)

P/L

114.53

2.29%

ROE

7.55%

P/VP

8.64

AZN - AstraZeneca

$164.27 2,88% (12 M)

P/L

23.89

1.99%

ROE

20.74%

P/VP

4.95

PFE - Pfizer

$28.67 23,78% (12 M)

P/L

35.72

6.28%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of ICON (ICLR) today?

A cotação de ICON (ICLR) hoje está em US$ 162.13, com uma variação de -8.83% em relação ao último ano. A cotação de ICON (ICLR) iniciou o ano negociando na casa dos US$ 182.22 e hoje está em US$ 162.13. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de ICON (ICLR) e dados de ações do Ibovespa e mercados internacionais.

Quando ICON (ICLR) paga dividendos?

ICON (ICLR) não distribuiu dividendos no último ano.

Is ICON (ICLR) a good investment?

Atualmente, ICON (ICLR) está cotada a US$ 162.13, com um P/L de 307.58, representando um desvio de 9,314% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -8.83 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -8.83%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ICON (ICLR) stock?

Investir em ações de ICON (ICLR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of ICON (ICLR) yield today?

A rentabilidade de ICON (ICLR) foi de 2.35% no último mês, -8.83% no último ano e -38.01% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de ICON (ICLR) hoje, o investimento total seria de US$ 16,213.00, com base na cotação atual de US$ 162.13.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 14,781.39
Em 5 anos: US$ 10,050.44
Em 10 anos: US$ 34,987.65

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ICLR

ICON Public Limited Company

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ICLR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

Graham's Fair Value

COMPARING ICLR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ICON

ICON Public Limited Company

United States

36 years

1998

14.650

PROFIT X PRICE ICLR

Financial Results ICLR

ICLR cash flow

Asset, Revenue and Profit Growth - ICLR

ICLR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions